Compare SMTI & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | CHPT |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.2M | 311.2M |
| IPO Year | 2008 | 2019 |
| Metric | SMTI | CHPT |
|---|---|---|
| Price | $32.54 | $11.46 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 7 |
| Target Price | ★ $35.00 | $7.50 |
| AVG Volume (30 Days) | 95.7K | ★ 879.4K |
| Earning Date | 11-12-2026 | 12-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,586,976.00 | ★ $411,224,000.00 |
| Revenue This Year | $13.07 | $7.92 |
| Revenue Next Year | $14.23 | $13.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $4.44 |
| 52 Week High | $35.52 | $12.97 |
| Indicator | SMTI | CHPT |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 62.47 |
| Support Level | $30.40 | $5.55 |
| Resistance Level | $34.01 | N/A |
| Average True Range (ATR) | 1.00 | 0.87 |
| MACD | 0.06 | 0.21 |
| Stochastic Oscillator | 75.84 | 67.74 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable charging systems owners, charge point operators, to manage their Networked Charging Systems, and to enable drivers to locate, reserve and authenticate Networked Charging Systems and to transact EV charging sessions on those systems. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. The company derives the majority of its revenue from the United States.